Tecan Group AG (SWX:TECN)

Market Cap	1.70B
Revenue (ttm)	906.60M
Net Income (ttm)	63.13M
Shares Out	12.70M
EPS (ttm)	4.95
PE Ratio	27.01
Forward PE	18.96
Dividend	3.00 (2.24%)
Ex-Dividend Date	Apr 14, 2025

Volume	20,671
Average Volume	37,984
Open	133.90
Previous Close	133.70
Day's Range	133.20 - 134.90
52-Week Range	131.50 - 248.00
Beta	1.28
RSI	37.51
Earnings Date	Mar 16, 2026

About Tecan Group AG

Tecan Group AG provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally. It operates in two segments, Life Sciences Business and Partnering Business. The company offers liquid handling and automation, microplate readers and washers, software, consumables, NGS reagents, immunoassays and antibodies, and Tecan Labwerx, an end-to-end automation solution. It also provides PARAMIT, a contract design and manufacturing service; Synergence, a customized O...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1980
• Employees: 3,341
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: TECN

Financial Performance

In 2024, Tecan Group AG's revenue was 934.28 million, a decrease of -13.04% compared to the previous year's 1.07 billion. Earnings were 67.66 million, a decrease of -48.77%.